Principles of Antimicrobial Chemotherapy and Antibacterial Resistance

Connect the major antimicrobial concepts into one rapid-revision pathway.

1. THE TOPIC IN ONE CONNECTED FLOW

Antimicrobial chemotherapy works when an active drug reaches a susceptible bacterium and successfully interferes with an essential bacterial target. The clinical result depends on the drug’s mechanism, the relationship between concentration and time, and whether the bacterium possesses resistance mechanisms that prevent effective drug-target interaction.

Antimicrobial selected

Empirical treatment, prophylaxis or directed use

→

Drug reaches bacterial target

Adequate active concentration is required

→

Essential process inhibited

Cell wall • ribosome • DNA/RNA • folate • membrane

→

Growth inhibited or bacteria killed

Bacteriostatic or bactericidal effect

→

Effect depends on exposure

Peak concentration or time above MIC

→

Resistance may interrupt the pathway

Drug loss, target change or pathway escape

Resistance interruption points

Drug inactivation
→
Reduced entry
→
Efflux
→
Target alteration
→
Metabolic bypass
→
Target overproduction

2. KEY CLINICAL CONNECTIONS

MIC and MBC

Lowest concentration stopping visible growth → MIC → inhibition does not prove bacterial death.

Higher concentration kills the bacterial population → MBC → bactericidal activity demonstrated.

Concentration versus Time

Aminoglycoside / fluoroquinolone → higher effective concentration → greater killing.

β-lactam → longer concentration above MIC → greater antibacterial effect.

Combination Therapy

Several likely pathogens or polymicrobial infection → combine appropriate drugs → broader coverage.

Two linked bacterial targets → sequential blockade → synergistic effect.

3. AIM HIGH-YIELD INTEGRATION REVIEW

⭐ MIC → growth inhibition; MBC → bacterial killing. Regrowth after drug removal suggests viable organisms remained.

Bacteriostatic action → multiplication stops → host immunity contributes importantly to bacterial clearance.

Bactericidal action → direct bacterial death through major disruption of an essential bacterial process.

⭐ Concentration-dependent killing → “How high?” Aminoglycosides and fluoroquinolones benefit from greater effective concentrations.

⭐ Time-dependent killing → “How long?” β-lactam efficacy depends mainly on maintaining concentration above the MIC.

Post-antibiotic effect → drug concentration falls below MIC → bacterial growth remains suppressed for a period.

⭐ Resistance → reduced effective drug-target interaction through inactivation, reduced entry, efflux, altered target, bypass or target overproduction.

Combination therapy → broader coverage or synergism, but unnecessary combinations may add toxicity, interactions and antimicrobial selection pressure.

AIM Exam Trap: MIC tells you when visible growth stops; it does not by itself prove that the bacteria have been killed. MBC addresses bacterial killing.